{"id":1315872,"date":"2024-08-13T06:05:11","date_gmt":"2024-08-13T06:05:11","guid":{"rendered":"https:\/\/teknomers.com\/es\/bristol-myers-pagara-a-evotec-75-millones-de-dolares-por-avances-en-pegamentos-moleculares\/"},"modified":"2024-08-13T06:05:15","modified_gmt":"2024-08-13T06:05:15","slug":"bristol-myers-pagara-a-evotec-75-millones-de-dolares-por-avances-en-pegamentos-moleculares","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/bristol-myers-pagara-a-evotec-75-millones-de-dolares-por-avances-en-pegamentos-moleculares\/","title":{"rendered":"Bristol Myers pagar\u00e1 a Evotec 75 millones de d\u00f3lares por avances en pegamentos moleculares"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>  FRANCFORT (Dow Jones)&#8211;Evotec recibir\u00e1 75 millones de d\u00f3lares de Bristol Myers Squibb como parte del desarrollo de una l\u00ednea de los llamados pegamentos moleculares. Estos est\u00e1n dirigidos a objetivos de alto valor en el campo de la oncolog\u00eda y m\u00e1s all\u00e1, anunci\u00f3 Evotec. La asociaci\u00f3n estrat\u00e9gica entre ambas partes se remonta a 2018 y se ampli\u00f3 en 2022. <\/p>\n<p>  P\u00f3ngase en contacto con el autor: Unternehmer.de@dowjones.com <\/p>\n<p>  DJG\/rio\/kla <\/p>\n<p>  (FIN) Noticias del Dow Jones<\/p>\n<p>  13 de agosto de 2024 01:59 ET (05:59 GMT)<\/p>\n<\/div>\n<div id=\"\">\n<h2 class=\"headline headline--h4\">Productos apalancados seleccionados en Bristol-Myers Squibb<\/h2>\n<p>Con los knock-outs, los inversores especulativos pueden participar desproporcionadamente en los movimientos de precios. Simplemente seleccione la palanca que desee y le mostraremos los productos abiertos adecuados en Bristol-Myers Squibb.<\/p>\n<p class=\"font-color-red display-none\" id=\"lvgCustomHandleInfo\">El apalancamiento debe estar entre 2 y 20<\/p>\n<p><span class=\"ad-hint ad-hint--right display-block\">Publicidad<\/span><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/bristol-myers-zahlt-evotec-75-mio-dollar-fuer-fortschritte-bei-molecular-glues-13760714\" rel=\"nofollow noopener\" target=\"_blank\">ttn-es-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FRANCFORT (Dow Jones)&#8211;Evotec recibir\u00e1 75 millones de d\u00f3lares de Bristol Myers Squibb como parte del desarrollo de una<\/p>\n","protected":false},"author":1,"featured_media":1230996,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[9225,72786,1942,102644,327,247753,62937,2866,247752,231],"class_list":["post-1315872","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finanzas","tag-avances","tag-bristol","tag-dolares","tag-evotec","tag-millones","tag-moleculares","tag-myers","tag-pagara","tag-pegamentos","tag-por"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/1315872","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=1315872"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/1315872\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/1230996"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=1315872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=1315872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=1315872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}